- Home
- ANIP vs EVT Comparison
ANIP vs EVT Comparison
Compare ANIP & EVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANIP
- EVT
- Stock Information
- Founded
- ANIP 2001
- EVT 2003
- Country
- ANIP United States
- EVT United States
- Employees
- ANIP N/A
- EVT N/A
- Industry
- ANIP Biotechnology: Pharmaceutical Preparations
- EVT Finance Companies
- Sector
- ANIP Health Care
- EVT Finance
- Exchange
- ANIP Nasdaq
- EVT Nasdaq
- Market Cap
- ANIP 2.0B
- EVT 1.9B
- IPO Year
- ANIP N/A
- EVT N/A
- Fundamental
- Price
- ANIP $95.75
- EVT $24.29
- Analyst Decision
- ANIP Strong Buy
- EVT
- Analyst Count
- ANIP 9
- EVT 0
- Target Price
- ANIP $89.11
- EVT N/A
- AVG Volume (30 Days)
- ANIP 394.4K
- EVT 115.5K
- Earning Date
- ANIP 11-07-2025
- EVT 01-01-0001
- Dividend Yield
- ANIP N/A
- EVT 8.32%
- EPS Growth
- ANIP N/A
- EVT N/A
- EPS
- ANIP N/A
- EVT 6.63
- Revenue
- ANIP $747,399,000.00
- EVT $69,404,302.00
- Revenue This Year
- ANIP $39.36
- EVT N/A
- Revenue Next Year
- ANIP $9.45
- EVT N/A
- P/E Ratio
- ANIP N/A
- EVT $3.55
- Revenue Growth
- ANIP 38.68
- EVT N/A
- 52 Week Low
- ANIP $52.50
- EVT $19.20
- 52 Week High
- ANIP $99.50
- EVT $25.83
- Technical
- Relative Strength Index (RSI)
- ANIP 63.57
- EVT 53.18
- Support Level
- ANIP $95.11
- EVT $24.23
- Resistance Level
- ANIP $99.39
- EVT $24.44
- Average True Range (ATR)
- ANIP 2.27
- EVT 0.19
- MACD
- ANIP -0.89
- EVT -0.02
- Stochastic Oscillator
- ANIP 50.13
- EVT 42.08
About ANIP ANI Pharmaceuticals Inc.
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.
About EVT Eaton Vance Tax Advantaged Dividend Income Fund of Beneficial Interest
EATON VANCE TAX ADVANTAGED DIVIDEND INCOME FUND is a diversified, closed-end management investment company. Its objective is to provide a high level of after-tax total return consisting mainly of tax-advantaged dividend income and capital appreciation. The fund pursues its objective by investing in dividend-paying common and preferred stocks. Its portfolio of investments consists of electric utilities, energy equipment and services, food products, health care providers and services, internet software and services, and other areas.